Richard Logan

Summary

Affiliation: University of Nottingham
Country: UK

Publications

  1. ncbi Commentary: preventing colorectal cancer with aspirin what next?
    Richard Logan
    Division of Epidemiology and Public Health, Queens Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK
    Int J Epidemiol 36:960-2. 2007
  2. ncbi Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests
    Richard F A Logan
    Division of Epidemiology and Public Health, University of Nottingham Medical School, Nottingham NG7 2UH, UK
    Gut 61:1439-46. 2012
  3. ncbi Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit
    Sarah A Hearnshaw
    Division of Epidemiology and Public Health, School of Community Health Sciences, University of Nottingham Medical School, Queen s Medical Centre, Nottingham NG7 2UH, UK
    Gut 59:1022-9. 2010
  4. ncbi Aspirin and folic acid for the prevention of recurrent colorectal adenomas
    Richard F A Logan
    Division of Epidemiology and Public Health, University of Nottingham, University Hospital, Nottingham, United Kingdom
    Gastroenterology 134:29-38. 2008
  5. ncbi Smoking and hepato-biliary disease
    R F Logan
    Division of Public Health and Epidemiology, University Hospital, Queen s Medical Centre, Nottingham, UK
    Eur J Gastroenterol Hepatol 12:863-7. 2000
  6. ncbi How often is a positive faecal occult blood test the result of coeliac disease?
    Richard F A Logan
    Department of Epidemiology and Public Health, University Hospital, University of Nottingham, Nottingham, UK
    Eur J Gastroenterol Hepatol 15:1097-100. 2003
  7. ncbi Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
    Julia Hippisley-Cox
    Division of Primary Care, University of Nottingham, Nottingham NG2 7RD
    BMJ 331:1310-6. 2005
  8. ncbi Mortality in inflammatory bowel disease: a population-based cohort study
    Tim Card
    Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, University of Nottingham, United Kingdom
    Gastroenterology 125:1583-90. 2003
  9. ncbi Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease
    Maeve M Skelly
    Division of Gastroenterology, Department of Pathology, University Hospital, Queen s Medical Center, Nottingham, NG7 2UH, England, U K
    Inflamm Bowel Dis 8:93-7. 2002
  10. ncbi Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment
    Nina R Lewis
    Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK
    Br J Nutr 102:509-13. 2009

Detail Information

Publications23

  1. ncbi Commentary: preventing colorectal cancer with aspirin what next?
    Richard Logan
    Division of Epidemiology and Public Health, Queens Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK
    Int J Epidemiol 36:960-2. 2007
  2. ncbi Outcomes of the Bowel Cancer Screening Programme (BCSP) in England after the first 1 million tests
    Richard F A Logan
    Division of Epidemiology and Public Health, University of Nottingham Medical School, Nottingham NG7 2UH, UK
    Gut 61:1439-46. 2012
    ..Subjects aged 60-69 are being invited to complete three guaiac faecal occult blood tests (6 windows) every 2 years. The programme aims to reduce mortality from colorectal cancer by 16% in those invited for screening...
  3. ncbi Use of endoscopy for management of acute upper gastrointestinal bleeding in the UK: results of a nationwide audit
    Sarah A Hearnshaw
    Division of Epidemiology and Public Health, School of Community Health Sciences, University of Nottingham Medical School, Queen s Medical Centre, Nottingham NG7 2UH, UK
    Gut 59:1022-9. 2010
    ..To assess the organisation of endoscopy services for AUGIB in the UK. To examine the relationship between outcomes and out of hours (OOH) service provision...
  4. ncbi Aspirin and folic acid for the prevention of recurrent colorectal adenomas
    Richard F A Logan
    Division of Epidemiology and Public Health, University of Nottingham, University Hospital, Nottingham, United Kingdom
    Gastroenterology 134:29-38. 2008
    ..Dietary folate intake also has been found to be associated with a reduced risk of colorectal neoplasms in observational studies...
  5. ncbi Smoking and hepato-biliary disease
    R F Logan
    Division of Public Health and Epidemiology, University Hospital, Queen s Medical Centre, Nottingham, UK
    Eur J Gastroenterol Hepatol 12:863-7. 2000
    ..As smoking is so prevalent in many countries, the public health impact of even a weak causal relationship would be considerable...
  6. ncbi How often is a positive faecal occult blood test the result of coeliac disease?
    Richard F A Logan
    Department of Epidemiology and Public Health, University Hospital, University of Nottingham, Nottingham, UK
    Eur J Gastroenterol Hepatol 15:1097-100. 2003
    ..This study examines whether a positive FOB is a feature of coeliac disease and whether FOB-positive subjects need investigation for coeliac disease...
  7. ncbi Risk of adverse gastrointestinal outcomes in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis
    Julia Hippisley-Cox
    Division of Primary Care, University of Nottingham, Nottingham NG2 7RD
    BMJ 331:1310-6. 2005
    ..To determine the risk of an adverse upper gastrointestinal event in patients taking different cyclo-oxygenase-2 inhibitors compared with non-selective non-steroidal anti-inflammatory drugs...
  8. ncbi Mortality in inflammatory bowel disease: a population-based cohort study
    Tim Card
    Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, University of Nottingham, United Kingdom
    Gastroenterology 125:1583-90. 2003
    ..In general, previous studies were not contemporary and were unable to correct for likely confounders. We have performed a large cohort study to examine contemporary IBD related mortality in the United Kingdom...
  9. ncbi Toxicity of mycophenolate mofetil in patients with inflammatory bowel disease
    Maeve M Skelly
    Division of Gastroenterology, Department of Pathology, University Hospital, Queen s Medical Center, Nottingham, NG7 2UH, England, U K
    Inflamm Bowel Dis 8:93-7. 2002
    ..Moreover, as patients with UC may be unduly prone to colonic injury, MMF may not be a suitable drug for its treatment...
  10. ncbi Cholesterol profile in people with newly diagnosed coeliac disease: a comparison with the general population and changes following treatment
    Nina R Lewis
    Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, University of Nottingham, Nottingham NG7 2UH, UK
    Br J Nutr 102:509-13. 2009
    ..Any increase in risk of IHD or stroke in people with coeliac disease is unlikely due to an adverse cholesterol profile either before diagnosis or after treatment with a gluten-free diet...
  11. ncbi Fracture risk in people with celiac disease: a population-based cohort study
    Joe West
    University of Nottingham, Division of Epidemiology and Public Health, Queen s Medical Centre, Nottingham, UK
    Gastroenterology 125:429-36. 2003
    ..We performed a population-based cohort study by using the General Practice Research Database to quantify the fracture risk in people with celiac disease compared with the general population...
  12. ncbi The iceberg of celiac disease: what is below the waterline?
    Joe West
    Division of Epidemiology and Public Health, University of Nottingham, Medical School, Queen s Medical Centre, Nottingham, United Kingdom
    Clin Gastroenterol Hepatol 5:59-62. 2007
    ..We explored the relationships between anti-tissue transglutaminase antibody and indirect measures of malabsorption and disease activity in people with undetected celiac disease...
  13. ncbi Malignancy and mortality in people with coeliac disease: population based cohort study
    Joe West
    Division of Epidemiology and Public Health, University of Nottingham, Queen s Medical Centre, Nottingham NG7 2UH
    BMJ 329:716-9. 2004
    ..To quantify the risks of malignancy and mortality in people with coeliac disease compared with the general population...
  14. ncbi Genetic variants of UGT1A6 influence risk of colorectal adenoma recurrence
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom and Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, University of Nottingham, Nottingham, United Kingdom
    Clin Cancer Res 12:6585-9. 2006
    ..We aimed to further investigate the effect of these genetic variants on the development of colorectal neoplasia...
  15. ncbi Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study
    Masoud Solaymani-Dodaran
    University of Nottingham, Division of Epidemiology and Public Health, Medical School, Queen's Medical Centre, Nottingham, UK
    Am J Gastroenterol 100:2616-21. 2005
    ....
  16. ncbi Long-term mortality in people with celiac disease diagnosed in childhood compared with adulthood: a population-based cohort study
    Masoud Solaymani Dodaran
    University of Nottingham, Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, Nottingham NG7 2UH, United Kingdom
    Am J Gastroenterol 102:864-70. 2007
    ....
  17. ncbi Influence of ursodeoxycholic acid on the mortality and malignancy associated with primary biliary cirrhosis: a population-based cohort study
    Hannah Jackson
    University of Nottingham Medical School, Division of Epidemiology and Public Health, Medical School, Queen s Medical Centre, Nottingham, United Kingdom
    Hepatology 46:1131-7. 2007
    ..However, the observed effect of ursodeoxycholic acid was not statistically significant...
  18. ncbi Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit
    Sarah A Hearnshaw
    Department of Gastroenterology, Royal Victoria Infirmary, Newcastle upon Tyne, UK
    Gut 60:1327-35. 2011
    ..To describe the patient characteristics, diagnoses and clinical outcomes of patients presenting with acute upper gastrointestinal bleeding (AUGIB) in the 2007 UK Audit...
  19. ncbi Asymptomatic colorectal neoplasia and fecal characteristics: a case-control study of subjects participating in the nottingham fecal occult blood screening trial
    Julian Little
    Epidemiology Group, Department of Medicine and Therapeutics, Aberdeen University Medical School, United Kingdom
    Dis Colon Rectum 45:1233-41. 2002
    ..CONCLUSION: The study does not support an association between colorectal cancer and fecal bile acids or pH. However, there is evidence that increases in major bile acids are associated with villous adenomas...
  20. ncbi Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence
    Richard A Hubner
    Institute of Cancer Research, Section of Cancer Genetics, Sutton SM2 5NG, United Kingdom
    Int J Cancer 123:586-93. 2008
    ..02). These findings indicate dairy products, and in particular milk, have chemopreventive activity against CRA recurrence...
  21. ncbi Folate metabolism polymorphisms influence risk of colorectal adenoma recurrence
    Richard A Hubner
    Institute of Cancer Research, Section of Cancer Genetics, 15 Cotswold Road, Sutton SM2 5NG, United Kingdom
    Cancer Epidemiol Biomarkers Prev 15:1607-13. 2006
    ..These findings provide additional support for the hypothesis that germ line variants in folate metabolism genes influence the development of colorectal adenomas...
  22. ncbi Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton SM2 5NG, United Kingdom
    Int J Cancer 121:2001-4. 2007
    ..These data indicate that these polymorphisms are unlikely to influence CRA recurrence and cannot be used to identify individuals who derive benefit from aspirin intervention...
  23. ncbi Ornithine decarboxylase G316A genotype is prognostic for colorectal adenoma recurrence and predicts efficacy of aspirin chemoprevention
    Richard A Hubner
    Section of Cancer Genetics, Institute of Cancer Research, Sutton, United Kingdom
    Clin Cancer Res 14:2303-9. 2008
    ..We investigated the influence of ODC G316A on the chemopreventive activity of aspirin in colorectal adenoma (CRA) recurrence...